Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026, Jun 2026 and Sep 2026.
- Largest single sale: $915K (11,675 shares) of Tarsus Pharmaceuticals, Inc. on Sep 15, 2026. Filing
- Last sale before this period: Sep 8, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Director | Oct 15, 2020 | Sep 17, 2026 |
| GLAUKOS Corp (GKOS) | Former Director | Jun 24, 2015 | Jun 7, 2021 |
| Edwards Lifesciences (EW) | Former Director | May 11, 2009 | May 11, 2020 |
Also a director at
GLAUKOS Corp (GKOS) (no filing in the last 18 months), Edwards Lifesciences (EW) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Tarsus Pharmaceuticals, Inc.: sold 12,500 shares for $980K, under a disclosed plan; 201 shares vested. 1 filing: 1
- Jun 15, 2026, Tarsus Pharmaceuticals, Inc.: sold 12,500 shares for $776K, under a disclosed plan. 1 filing: 1
- Jun 12, 2026, Tarsus Pharmaceuticals, Inc.: 2,954 shares vested. 1 filing: 1
- Mar 16, 2026, Tarsus Pharmaceuticals, Inc.: sold 12,500 shares for $860K, under a disclosed plan. 1 filing: 1
- Dec 15, 2025, Tarsus Pharmaceuticals, Inc.: sold 22,946 shares for $1.9M, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.